CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C18404 | BRD-K50135923 | KU-C104491 | -- | -- | -- | Details |
| C18405 | BRD-K50140147 | NVP-TAE684 | ALK | ALK inhibitor | -- | Details |
| C18406 | BRD-K50140257 | BRD-K50140257 | -- | -- | -- | Details |
| C18407 | BRD-K50146114 | BRD-K50146114 | -- | -- | -- | Details |
| C18408 | BRD-K50146767 | BRD-K50146767 | -- | -- | -- | Details |
| C18409 | BRD-K50149017 | BRD-K50149017 | -- | -- | -- | Details |
| C18410 | BRD-K50149147 | BRD-K50149147 | -- | -- | -- | Details |
| C18411 | BRD-K50157358 | BRD-K50157358 | -- | -- | -- | Details |
| C18412 | BRD-K50157880 | BRD-K50157880 | -- | -- | -- | Details |
| C18413 | BRD-K50160200 | BRD-K50160200 | -- | -- | -- | Details |
| C18414 | BRD-K50162138 | BRD-K50162138 | -- | -- | -- | Details |
| C18415 | BRD-K50163129 | acrivastine | HRH1 | Histamine receptor antagonist | -- | Details |
| C18416 | BRD-K50168500 | canertinib | EGFR; ERBB2; ERBB4 | EGFR inhibitor | -- | Details |
| C18417 | BRD-K50171542 | BRD-K50171542 | -- | -- | -- | Details |
| C18418 | BRD-K50171760 | BRD-K50171760 | -- | -- | -- | Details |
| C18419 | BRD-K50174388 | BRD-K50174388 | -- | -- | -- | Details |
| C18420 | BRD-K50176356 | BRD-K50176356 | -- | -- | -- | Details |
| C18421 | BRD-K50177531 | BRD-K50177531 | -- | -- | -- | Details |
| C18422 | BRD-K50177754 | BRD-K50177754 | -- | -- | -- | Details |
| C18423 | BRD-K50177987 | BRD-K50177987 | -- | -- | -- | Details |
| C18424 | BRD-K50186544 | BRD-K50186544 | -- | -- | -- | Details |
| C18425 | BRD-K50190949 | BRD-K50190949 | -- | -- | -- | Details |
| C18426 | BRD-K50191826 | BRD-K50191826 | -- | -- | -- | Details |
| C18427 | BRD-K50194167 | BRD-K50194167 | -- | -- | -- | Details |
| C18428 | BRD-K50195301 | BRD-K50195301 | -- | -- | -- | Details |
| C18429 | BRD-K50199947 | WH-4023 | -- | -- | -- | Details |
| C18430 | BRD-K50201262 | BRD-K50201262 | -- | -- | -- | Details |
| C18431 | BRD-K50204028 | BRD-K50204028 | -- | -- | -- | Details |
| C18432 | BRD-K50210179 | BRD-K50210179 | -- | -- | -- | Details |
| C18433 | BRD-K50212643 | BRD-K50212643 | -- | -- | -- | Details |
| C18434 | BRD-K50214219 | CS-1657 | PARP1 | PARP inhibitor | -- | Details |
| C18435 | BRD-K50216176 | BRD-K50216176 | -- | -- | -- | Details |
| C18436 | BRD-K50216418 | BRD-K50216418 | -- | -- | -- | Details |
| C18437 | BRD-K50218580 | BRD-K50218580 | -- | -- | -- | Details |
| C18438 | BRD-K50218765 | BRD-K50218765 | -- | -- | -- | Details |
| C18439 | BRD-K50223932 | BRD-K50223932 | -- | -- | -- | Details |
| C18440 | BRD-K50230035 | BRD-K50230035 | -- | -- | -- | Details |
| C18441 | BRD-K50234570 | EMF-bca1-16 | -- | -- | -- | Details |
| C18442 | BRD-K50240676 | BRD-K50240676 | -- | -- | -- | Details |
| C18443 | BRD-K50247051 | BRD-K50247051 | -- | -- | -- | Details |
| C18444 | BRD-K50257410 | BRD-K50257410 | -- | -- | -- | Details |
| C18445 | BRD-K50260295 | BRD-K50260295 | -- | -- | -- | Details |
| C18446 | BRD-K50266413 | BRD-K50266413 | -- | -- | -- | Details |
| C18447 | BRD-K50269042 | BRD-K50269042 | -- | -- | -- | Details |
| C18448 | BRD-K50271780 | BRD-K50271780 | -- | -- | -- | Details |
| C18449 | BRD-K50272743 | BRD-K50272743 | -- | -- | -- | Details |
| C18450 | BRD-K50277523 | BRD-K50277523 | -- | -- | -- | Details |
| C18451 | BRD-K50278697 | BRD-K50278697 | -- | -- | -- | Details |
| C18452 | BRD-K50280607 | BRD-K50280607 | -- | -- | -- | Details |
| C18453 | BRD-K50281141 | BRD-K50281141 | -- | -- | -- | Details |
| C18454 | BRD-K50282595 | BRD-K50282595 | -- | -- | -- | Details |
| C18455 | BRD-K50287215 | BRD-K50287215 | -- | -- | -- | Details |
| C18456 | BRD-K50289629 | ARG-CSC-22 | -- | -- | -- | Details |
| C18457 | BRD-K50291875 | BRD-K50291875 | -- | -- | -- | Details |
| C18458 | BRD-K50293352 | MM77 | HTR1A | Serotonin receptor antagonist | MM-77 | Details |
| C18459 | BRD-K50297939 | UTMB-00530 | -- | -- | -- | Details |
| C18460 | BRD-K50298819 | BRD-K50298819 | -- | -- | -- | Details |
| C18461 | BRD-K50300854 | BRD-K50300854 | -- | -- | -- | Details |
| C18462 | BRD-K50301790 | BRD-K50301790 | -- | -- | -- | Details |
| C18463 | BRD-K50302985 | BRD-K50302985 | -- | -- | -- | Details |
| C18464 | BRD-K50309272 | BRD-K50309272 | -- | -- | -- | Details |
| C18465 | BRD-K50311478 | BRD-K50311478 | -- | -- | tosyl-phenylalanyl-chloromethyl-ketone | Details |
| C18466 | BRD-K50314382 | BRD-K50314382 | -- | -- | -- | Details |
| C18467 | BRD-K50315405 | BRD-K50315405 | -- | -- | -- | Details |
| C18468 | BRD-K50324045 | BRD-K50324045 | -- | -- | avrainvillamide-analog-6 | Details |
| C18469 | BRD-K50325075 | UCL-2077 | -- | -- | -- | Details |
| C18470 | BRD-K50325214 | BRD-K50325214 | -- | -- | -- | Details |
| C18471 | BRD-K50325283 | BRD-K50325283 | -- | -- | -- | Details |
| C18472 | BRD-K50325722 | BRD-K50325722 | -- | -- | -- | Details |
| C18473 | BRD-K50330857 | BRD-K50330857 | -- | -- | -- | Details |
| C18474 | BRD-K50342369 | BRD-K50342369 | -- | -- | -- | Details |
| C18475 | BRD-K50345393 | BRD-K50345393 | -- | -- | -- | Details |
| C18476 | BRD-K50347701 | BRD-K50347701 | -- | -- | -- | Details |
| C18477 | BRD-K50351738 | BRD-K50351738 | -- | -- | -- | Details |
| C18478 | BRD-K50358328 | BRD-K50358328 | -- | -- | -- | Details |
| C18479 | BRD-K50360395 | BRD-K50360395 | -- | -- | -- | Details |
| C18480 | BRD-K50360938 | BRD-K50360938 | -- | -- | -- | Details |
| C18481 | BRD-K50366616 | BRD-K50366616 | -- | -- | -- | Details |
| C18482 | BRD-K50367303 | BRD-K50367303 | -- | -- | -- | Details |
| C18483 | BRD-K50368246 | BRD-K50368246 | -- | -- | -- | Details |
| C18484 | BRD-K50381033 | BRD-K50381033 | -- | -- | -- | Details |
| C18485 | BRD-K50383095 | BRD-K50383095 | -- | -- | -- | Details |
| C18486 | BRD-K50384076 | BRD-K50384076 | -- | -- | 7,4'-dihydroxyflavone | Details |
| C18487 | BRD-K50387473 | XMD-892 | MAPK7 | MAP kinase inhibitor | -- | Details |
| C18488 | BRD-K50388099 | BRD-K50388099 | -- | -- | -- | Details |
| C18489 | BRD-K50388907 | fenofibrate | PPARA | PPAR receptor agonist | -- | Details |
| C18490 | BRD-K50388960 | BRD-K50388960 | -- | -- | -- | Details |
| C18491 | BRD-K50389815 | BRD-K50389815 | -- | -- | -- | Details |
| C18492 | BRD-K50398167 | meclofenamic-acid | PTGS1; PTGS2 | Cyclooxygenase inhibitor; Prostanoid receptor antagonist | -- | Details |
| C18493 | BRD-K50400833 | BRD-K50400833 | -- | -- | -- | Details |
| C18494 | BRD-K50404714 | BRD-K50404714 | -- | -- | -- | Details |
| C18495 | BRD-K50406511 | hycanthone | -- | -- | -- | Details |
| C18496 | BRD-K50408407 | BRD-K50408407 | -- | -- | -- | Details |
| C18497 | BRD-K50413145 | BRD-K50413145 | -- | -- | -- | Details |
| C18498 | BRD-K50417536 | BRD-K50417536 | -- | -- | -- | Details |
| C18499 | BRD-K50417881 | eticlopride | DRD2 | Dopamine receptor antagonist | -- | Details |
| C18500 | BRD-K50422030 | clomethiazole | GABRA1 | GABA receptor modulator; GABA receptor antagonist | -- | Details |
| C18501 | BRD-K50423606 | BRD-K50423606 | -- | -- | -- | Details |
| C18502 | BRD-K50424430 | BRD-K50424430 | -- | -- | -- | Details |
| C18503 | BRD-K50432649 | BRD-K50432649 | -- | -- | -- | Details |